Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03113669 · ClinicalTrials.gov registry record · NA
Project BITE: Binge Intervention Target Effectiveness
A NA study of Binge-Eating Disorder, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03113669: Completed NA study of Binge-Eating Disorder, sponsored by Drexel University.
NCT03113669 is a NA study of Binge-Eating Disorder that has completed, run by Drexel University. The registered enrollment target is 20 participants, below the 1,143-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03113669, a NA study of Binge-Eating Disorder, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to determine how inhibitory neurobiological and neurocognitive processes relate to binge eating treatment outcome.
Primary Outcome
The Eating Disorder Examination is a widely utilized, semi-structured interview for the assessment of eating disorder symptoms and the binge-eating module will be used to determine binge episode frequency.
Conditions Studied
Interventions
- BEHAVIORAL CBT-GSH
Study Locations (1)
Pennsylvania
- Drexel University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2016-10-06 |
| Est. Completion | 2018-02-15 |
| Phase | NA |
What the finished NCT03113669 record still lists
NCT03113669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,143-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Binge-Eating Disorder appearing as the primary indexed condition, and to 1 intervention - of which CBT-GSH is the first listed.
NCT03113669 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03113669 about?
NCT03113669 is a clinical study titled "Project BITE: Binge Intervention Target Effectiveness". The primary aim of this study is to determine how inhibitory neurobiological and neurocognitive processes relate to binge eating treatment outcome.
What is the current status of trial NCT03113669?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2016-10-06. Estimated completion is 2018-02-15.
What conditions does trial NCT03113669 study?
This clinical trial studies the following conditions: Binge-Eating Disorder.
What interventions are being tested in trial NCT03113669?
The interventions under investigation include: CBT-GSH (BEHAVIORAL).
Who is sponsoring clinical trial NCT03113669?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03113669 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Binge-Eating Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03113669's enrollment target sits among peer trials
20 34th of 37 higher than 3 of 37 other Binge-Eating Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Binge-Eating Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
-
Treating Binge Eating and Obesity Digitally in Black Women
RECRUITING · NA
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
RECRUITING · NA
-
Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI